[Changes of plasma levels of type C natriuretic peptide in patients with pregnancy induced hypertension].
Z Gao, Y Zhang, Li Z
Abstract
Z Gao, Y Zhang, Li Z
Abstract
OBJECTIVE: To investigate the changes and clinical significance of plasma type C natriuretic peptide (CNP) concentration in patients with pregnancy induced hypertension (PIH). METHODS: Plasma CNP levels were detected by radioimmunoassay in 89 patients with PIH, 193 normal pregnant women and 46 normal non-pregnant women. Outcomes were statistically analyzed by one-way analysis of variance and Student-Nawman-Kenls (SNK) test. RESULTS: The plasma CNP levels in patients with PIH [(30.51 +/- 33.61) ng/L] were significantly higher than those of normal non-pregnant women and normal pregnancies [(17.15 +/- 3.82) ng/L, (19.43 +/- 5.13) ng/L, respectively; F = 13.61, P < 0.01]. There was significant difference among plasma CNP levels from patients with mild, moderate, and severe PIH (P < 0.0001). CONCLUSIONS: The changes of plasma CNP levels are believed to be the reflection of patients in progression of PIH and can be used as a biochemical marker for judging the progression and guiding the therapy of PIH.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate the changes and clinical significance of plasma type C natriuretic peptide (CNP) concentration in patients with pregnancy induced hypertension (PIH). METHODS: Plasma CNP levels were detected by radioimmunoassay in 89 patients with PIH, 193 normal pregnant women and 46 normal non-pregnant women. Outcomes were statistically analyzed by one-way analysis of variance and Student-Nawman-Kenls (SNK) test. RESULTS: The plasma CNP levels in patients with PIH [(30.51 +/- 33.61) ng/L] were significantly higher than those of normal non-pregnant women and normal pregnancies [(17.15 +/- 3.82) ng/L, (19.43 +/- 5.13) ng/L, respectively; F = 13.61, P < 0.01]. There was significant difference among plasma CNP levels from patients with mild, moderate, and severe PIH (P < 0.0001). CONCLUSIONS: The changes of plasma CNP levels are believed to be the reflection of patients in progression of PIH and can be used as a biochemical marker for judging the progression and guiding the therapy of PIH.
Key concepts: Medicine, Internal medicine, Natriuretic peptide, Radioimmunoassay, Endocrinology, Plasma levels, Pregnancy, Analysis of variance